Adtalem Global Education (NYSE:CVSA) Issues FY 2026 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 7.950-8.150 for the period, compared to the consensus earnings per share estimate of 7.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion.

Adtalem Global Education Price Performance

Shares of NYSE:CVSA traded up $12.72 during midday trading on Friday, hitting $129.72. The company had a trading volume of 389,159 shares, compared to its average volume of 390,218. Adtalem Global Education has a 12-month low of $86.97 and a 12-month high of $156.26. The business has a fifty day simple moving average of $110.78. The firm has a market cap of $4.48 billion, a P/E ratio of 19.07, a price-to-earnings-growth ratio of 0.98 and a beta of 0.63. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.68 and a current ratio of 0.68.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Research analysts expect that Adtalem Global Education will post 7.86 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Truist Financial began coverage on Adtalem Global Education in a research report on Tuesday, March 24th. They set a “buy” rating and a $130.00 target price for the company. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Weiss Ratings started coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Finally, Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $150.00.

Insider Buying and Selling at Adtalem Global Education

In related news, Director Michael W. Malafronte bought 8,890 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was bought at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the purchase, the director directly owned 25,395 shares of the company’s stock, valued at approximately $2,563,371.30. This trade represents a 53.86% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders bought a total of 37,236 shares of company stock worth $3,752,866 in the last 90 days. 2.50% of the stock is currently owned by insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.